Ledaga 
Procedural steps taken and scientific information after the authorisation 
Application 
Scope 
number 
Opinion/ 
Commission 
Product 
Summary 
Notification1 
Decision 
Information 
issued on 
Issued2 / 
affected3  
amended 
on 
IB/0036/G 
This was an application for a group of variations. 
07/09/2023 
SmPC 
B.II.e.1.b.1 - Change in immediate packaging of the 
finished product - Change in type/addition of a new 
container - Solid, semi-solid and non-sterile liquid 
pharmaceutical forms 
1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions 
are issued for all other procedures. 
2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The 
CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures. 
3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet). 
Official address  Domenico Scarlattilaan 6  ●  1083 HS Amsterdam  ●  The Netherlands 
Address for visits and deliveries  Refer to www.ema.europa.eu/how-to-find-us  
Send us a question  Go to www.ema.europa.eu/contact   Telephone +31 (0)88 781 6000 
An agency of the European Union 
 
 
 
 
 
 
  
 
 
 
 
 
B.II.b.1.e - Replacement or addition of a 
manufacturing site for the FP - Site where any 
manufacturing operation(s) take place, except batch-
release, batch control, primary and secondary 
packaging, for non-sterile medicinal products 
B.II.b.3.a - Change in the manufacturing process of 
the finished or intermediate product - Minor change 
in the manufacturing process 
B.II.b.3.z - Change in the manufacturing process of 
the finished or intermediate product - Other variation 
B.II.b.1.b - Replacement or addition of a 
manufacturing site for the FP - Primary packaging 
site 
B.II.f.1.b.1 - Stability of FP - Extension of the shelf 
life of the finished product - As packaged for sale 
(supported by real time data) 
B.II.b.5.b - Change to in-process tests or limits 
applied during the manufacture of the finished 
product - Addition of a new test(s) and limits 
IA/0034 
A.5.b - Administrative change - Change in the name 
09/09/2022 
n/a 
and/or address of a manufacturer/importer of the 
finished product, including quality control sites 
(excluding manufacturer for batch release) 
IA/0033/G 
This was an application for a group of variations. 
09/09/2022 
n/a 
A.4 - Administrative change - Change in the name 
and/or address of a manufacturer or an ASMF holder 
or supplier of the AS, starting material, reagent or 
intermediate used in the manufacture of the AS or 
Page 2/9 
 
 
 
 
 
 
 
 
 
 
 
 
manufacturer of a novel excipient 
A.4 - Administrative change - Change in the name 
and/or address of a manufacturer or an ASMF holder 
or supplier of the AS, starting material, reagent or 
intermediate used in the manufacture of the AS or 
manufacturer of a novel excipient 
A.7 - Administrative change - Deletion of 
manufacturing sites 
IB/0032 
B.II.d.1.z - Change in the specification parameters 
11/04/2022 
n/a 
and/or limits of the finished product - Other variation 
PSUSA/10587
Periodic Safety Update EU Single assessment - 
10/03/2022 
n/a 
PRAC Recommendation - maintenance 
/202108 
chlormethine 
R/0030 
Renewal of the marketing authorisation. 
11/11/2021 
07/01/2022 
SmPC, Annex 
Based on the review of data on quality, safety and efficacy, 
II, Labelling 
the CHMP considered that the benefit-risk balance of 
and PL 
LEDAGA in the approved indication remains favourable and 
therefore recommended the renewal of the marketing 
authorisation with unlimited validity. 
IB/0029 
B.II.f.1.b.1 - Stability of FP - Extension of the shelf 
12/05/2021 
07/01/2022 
SmPC 
life of the finished product - As packaged for sale 
(supported by real time data) 
IB/0028/G 
This was an application for a group of variations. 
26/04/2021 
n/a 
B.II.d.2.d - Change in test procedure for the finished 
product - Other changes to a test procedure 
(including replacement or addition) 
B.II.b.2.a - Change to importer, batch release 
arrangements and quality control testing of the FP - 
Page 3/9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Replacement/addition of a site where batch 
control/testing takes place 
PSUSA/10587
Periodic Safety Update EU Single assessment - 
11/03/2021 
n/a 
PRAC Recommendation - maintenance 
/202008 
chlormethine 
IB/0026 
B.II.f.1.d - Stability of FP - Change in storage 
25/02/2021 
07/01/2022 
SmPC, 
conditions of the finished product or the 
diluted/reconstituted product 
Labelling and 
PL 
IB/0025/G 
This was an application for a group of variations. 
11/12/2020 
n/a 
B.I.z - Quality change - Active substance - Other 
variation 
B.I.z - Quality change - Active substance - Other 
variation 
B.II.b.5.z - Change to in-process tests or limits 
applied during the manufacture of the finished 
product - Other variation 
PSUSA/10587
Periodic Safety Update EU Single assessment - 
01/10/2020 
n/a 
PRAC Recommendation - maintenance 
/202002 
chlormethine 
IA/0023/G 
This was an application for a group of variations. 
06/08/2020 
n/a 
B.I.a.1.f - Change in the manufacturer of AS or of a 
starting material/reagent/intermediate for AS - 
Changes to quality control testing arrangements for 
the AS -replacement or addition of a site where 
batch control/testing takes place 
B.II.d.2.f - Change in test procedure for the finished 
Page 4/9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
product - To reflect compliance with the Ph. Eur. and 
remove reference to the outdated internal test 
method and test method number 
B.II.d.2.f - Change in test procedure for the finished 
product - To reflect compliance with the Ph. Eur. and 
remove reference to the outdated internal test 
method and test method number 
B.II.d.2.f - Change in test procedure for the finished 
product - To reflect compliance with the Ph. Eur. and 
remove reference to the outdated internal test 
method and test method number 
IB/0022 
B.II.d.2.d - Change in test procedure for the finished 
21/07/2020 
n/a 
product - Other changes to a test procedure 
(including replacement or addition) 
IB/0020/G 
This was an application for a group of variations. 
17/07/2020 
n/a 
A.5.b - Administrative change - Change in the name 
and/or address of a manufacturer/importer of the 
finished product, including quality control sites 
(excluding manufacturer for batch release) 
B.II.b.2.a - Change to importer, batch release 
arrangements and quality control testing of the FP - 
Replacement/addition of a site where batch 
control/testing takes place 
B.II.d.2.d - Change in test procedure for the finished 
product - Other changes to a test procedure 
(including replacement or addition) 
PSUSA/10587
Periodic Safety Update EU Single assessment - 
12/03/2020 
n/a 
PRAC Recommendation - maintenance 
Page 5/9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
/201908 
chlormethine 
N/0017 
Minor change in labelling or package leaflet not 
14/10/2019 
28/02/2020 
Labelling 
connected with the SPC (Art. 61.3 Notification) 
IAIN/0018 
B.II.b.1.a - Replacement or addition of a 
11/10/2019 
n/a 
manufacturing site for the FP - Secondary packaging 
site 
IB/0016 
B.II.d.1.d - Change in the specification parameters 
17/09/2019 
n/a 
and/or limits of the finished product - Deletion of a 
non-significant specification parameter 
PSUSA/10587
Periodic Safety Update EU Single assessment - 
05/09/2019 
n/a 
PRAC Recommendation - maintenance 
/201902 
chlormethine 
IB/0015 
B.I.b.2.e - Change in test procedure for AS or 
23/08/2019 
n/a 
starting material/reagent/intermediate - Other 
changes to a test procedure (including replacement 
or addition) for the AS or a starting 
material/intermediate 
IAIN/0012 
B.II.b.2.c.1 - Change to importer, batch release 
10/05/2019 
n/a 
arrangements and quality control testing of the FP - 
Replacement or addition of a manufacturer 
responsible for importation and/or batch release - 
Not including batch control/testing 
N/0011 
Minor change in labelling or package leaflet not 
09/04/2019 
28/02/2020 
PL 
connected with the SPC (Art. 61.3 Notification) 
Page 6/9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IB/0009/G 
This was an application for a group of variations. 
03/04/2019 
n/a 
B.I.a.1.f - Change in the manufacturer of AS or of a 
starting material/reagent/intermediate for AS - 
Changes to quality control testing arrangements for 
the AS -replacement or addition of a site where 
batch control/testing takes place 
B.I.b.1.h - Change in the specification parameters 
and/or limits of an AS, starting 
material/intermediate/reagent - Addition or 
replacement (excl. Biol. or immunol. substance) of a 
specification parameter as a result of a safety or 
quality issue 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.I.b.2.e - Change in test procedure for AS or 
starting material/reagent/intermediate - Other 
changes to a test procedure (including replacement 
or addition) for the AS or a starting 
material/intermediate 
B.I.b.2.e - Change in test procedure for AS or 
starting material/reagent/intermediate - Other 
changes to a test procedure (including replacement 
or addition) for the AS or a starting 
material/intermediate 
B.I.b.2.e - Change in test procedure for AS or 
starting material/reagent/intermediate - Other 
changes to a test procedure (including replacement 
Page 7/9 
 
 
 
 
 
 
 
 
or addition) for the AS or a starting 
material/intermediate 
B.I.b.2.e - Change in test procedure for AS or 
starting material/reagent/intermediate - Other 
changes to a test procedure (including replacement 
or addition) for the AS or a starting 
material/intermediate 
IAIN/0010/G 
This was an application for a group of variations. 
15/03/2019 
28/02/2020 
Annex II, 
Labelling and 
PL 
A.5.b - Administrative change - Change in the name 
and/or address of a manufacturer/importer of the 
finished product, including quality control sites 
(excluding manufacturer for batch release) 
A.7 - Administrative change - Deletion of 
manufacturing sites 
A.7 - Administrative change - Deletion of 
manufacturing sites 
B.II.b.2.c.1 - Change to importer, batch release 
arrangements and quality control testing of the FP - 
Replacement or addition of a manufacturer 
responsible for importation and/or batch release - 
Not including batch control/testing 
PSUSA/10587
Periodic Safety Update EU Single assessment - 
14/03/2019 
n/a 
PRAC Recommendation - maintenance 
/201808 
chlormethine 
T/0008 
Transfer of Marketing Authorisation 
22/11/2018 
18/12/2018 
SmPC, 
Labelling and 
PL 
Page 8/9 
 
 
 
 
 
 
 
 
 
 
 
 
 
PSUSA/10587
Periodic Safety Update EU Single assessment - 
06/09/2018 
n/a 
PRAC Recommendation - maintenance 
/201802 
chlormethine 
PSUSA/10587
Periodic Safety Update EU Single assessment - 
08/03/2018 
n/a 
PRAC Recommendation - maintenance 
/201708 
chlormethine 
IG/0839 
B.II.b.2.c.1 - Change to importer, batch release 
20/11/2017 
28/05/2018 
SmPC, Annex 
arrangements and quality control testing of the FP - 
II and PL 
Replacement or addition of a manufacturer 
responsible for importation and/or batch release - 
Not including batch control/testing 
IB/0003/G 
This was an application for a group of variations. 
15/09/2017 
n/a 
B.II.z - Quality change - Finished product - Other 
variation 
B.II.z - Quality change - Finished product - Other 
variation 
IA/0001 
B.II.d.1.d - Change in the specification parameters 
28/06/2017 
28/05/2018 
SmPC and PL 
and/or limits of the finished product - Deletion of a 
non-significant specification parameter 
Page 9/9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
